Semia – Dianosic in the press

Semia – Dianosic in the press 540 250 Philippe Bastide

Seen in Innovation Review (translation of the article published on December 16th, 2018):

“The healthcare sector is bubbling since the combined rise of digital technologie, imaging or materials allowed to multiply the number of innovations in this area. “Innovation Review” performed a selection of the most promising startups in the field of e-health, Medtechs and Biotechs.


DIANOSIC (startup)

Treatments for the nasal cavity

The startup founded in 2017, develops two technologies. Balloons for the treatment of nose bleeding, and stents (sic) for pathologies of the nasal fossa (sic) such as epistaxis (sic) or chronic sinusitis. Those devices combine several technological layers, including an active coating to promote healing, and connectivity to contribute to an optimal remote monitoring for patients. The startup expects to kick off its clinical trials this year.

Incubator : Semia
Distinction : Wilco 2018 (Paris startup accelerator)”